Table 2.
Patient clinical characteristics at HT
| Characteristic | No GS (N = 2204) | Confirmed GS (N = 225) | P value |
|---|---|---|---|
| PAP, mm Hg, median (IQR) | 22 (17-30) | 20 (17-31) | .93 |
| Creatinine, mg/dL, median (IQR) | 0.4 (0.3-0.6) | 0.4 (0.3-0.6) | .44 |
| Dialysis, % | 2.7% | 4.0% | .29 |
| Bilirubin, mg/dL, median (IQR) | 0.5 (0.3-1.0) | 0.6 (0.3-1.0) | .17 |
| Mechanical ventilation, % | 15% | 16% | .77 |
| EMCO, % | 3.4% | 2.2% | .43 |
| VAD, % | 23% | 18% | .26 |
| Inotropes, % | 52% | 47% | .19 |
| Donor ischemia time, min, median (IQR) | 3.5 (2.9-4.1) | 3.5 (3.0-4.1) | .49 |
| Waitlist time, d, median (IQR) | 53 (20-113) | 55 (20-135) | .40 |
HT, Heart transplant; GS, genetic syndrome; PAP, pulmonary artery pressure; IQR, interquartile range; ECMO, extracorporeal membrane oxygenation; VAD, ventricular assist device.